Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial

Lakshminarayan R. Ranganath, Eftychia Eirini Psarelli, Jean Baptiste Arnoux, Daniela Braconi, Michael Briggs, Anders Bröijersén, Nadia Loftus, Helen Bygott, Trevor F. Cox, Andrew S. Davison, Jane P. Dillon, Michael Fisher, Richard FitzGerald, Federica Genovese, Helena Glasova, Anthony K. Hall, Andrew T. Hughes, Juliette H. Hughes, Richard Imrich, Jonathan C. JarvisMilad Khedr, Dinny Laan, Kim Hanh Le Quan Sang, Emily Luangrath, Ol'ga Lukáčová, Anna M. Milan, Alpesh Mistry, Vanda Mlynáriková, Brendan P. Norman, Birgitta Olsson, Nicholas P. Rhodes, Jozef Rovenský, Mattias Rudebeck, Annalisa Santucci, Ella Shweihdi, Ciarán Scott, Jana Sedláková, Nicolas Sireau, Roman Stančík, Johan Szamosi, Sophie Taylor, Christa van Kan, Sobhan Vinjamuri, Eva Vrtíková, Chris Webb, Elizabeth West, Elizabeth Záňová, Andrea Zatkova, James A. Gallagher

Research output: Contribution to journalArticle (journal)peer-review

67 Citations (Scopus)
78 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science